APC
ELV icon

Aspire Private Capital’s Elevance Health ELV Stock Holding History

Aspire Private Capital’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$374K Sell
967
-103
-10% -$38.2K 0.08% 134
2026
Q1 		$313K Sell
1,070
-46
-4% -$15.1K 0.07% 140
2025
Q4 		$391K Sell
1,116
-12
-1% -$4.05K 0.09% 132
2025
Q3 		$365K Buy
1,128
+111
+11% +$34.5K 0.08% 140
2025
Q2 		$395K Buy
1,017
+369
+57% +$148K 0.09% 142
2025
Q1 		$282K Buy
+648
New +$260K 0.07% 157
2024
Q4 		– Sell
-37
Closed -$19.2K – 300
2024
Q3 		$19.2K Hold
37
– – ﹤0.01% 309
2024
Q2 		$20K Sell
37
-10
-21% -$5.29K 0.01% 315
2024
Q1 		$24.3K Sell
47
-11
-19% -$5.47K 0.01% 300
2023
Q4 		$27.6K Sell
58
-1,292
-96% -$597K 0.01% 274
2023
Q3 		$588K Buy
1,350
+70
+5% +$31.8K 0.19% 79
2023
Q2 		$569K Buy
1,280
+52
+4% +$24K 0.18% 90
2023
Q1 		$565K Buy
1,228
+1,216
+10,133% +$579K 0.19% 89
2022
Q4 		$6.22K Hold
12
– – ﹤0.01% 410
2022
Q3 		$5K Hold
12
– – ﹤0.01% 414
2022
Q2 		$6K Hold
12
– – ﹤0.01% 380
2022
Q1 		$6K Sell
12
-8
-40% -$3.66K ﹤0.01% 375
2021
Q4 		$9K Buy
20
+8
+67% +$3.37K ﹤0.01% 348
2021
Q3 		$4K Hold
12
– – ﹤0.01% 406
2021
Q2 		$5K Hold
12
– – ﹤0.01% 385
2021
Q1 		$4K Buy
12
+6
+100% +$1.93K ﹤0.01% 405
2020
Q4 		$2K Hold
6
– – ﹤0.01% 375
2020
Q3 		$2K Hold
6
– – ﹤0.01% 372
2020
Q2 		$2K Hold
6
– – ﹤0.01% 267
2020
Q1 		$1K Hold
6
– – ﹤0.01% 205
2019
Q4 		$2K Sell
6
-9
-60% -$2.48K ﹤0.01% 374
2019
Q3 		$4K Hold
15
– – ﹤0.01% 294
2019
Q2 		$4K Buy
15
+8
+114% +$2.19K ﹤0.01% 327
2019
Q1 		$2K Hold
7
– – ﹤0.01% 427
2018
Q4 		$2K Buy
+7
New +$1.93K ﹤0.01% 409

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Aspire Private Capital's ELV Position: Q2 2026 in Review

Aspire Private Capital reduced its Elevance Health (ELV) stake by 9.6% in Q2 2026, selling an estimated $38.2K and leaving 967 shares worth $374K. The position accounts for 0.08% of the portfolio, ranked #134.

Aspire Private Capital first reported a position in ELV in Q4 2018 and has held it in 30 quarters since. The position peaked at $588K in Q3 2023. 1,600 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Aspire Private Capital held 967 shares of Elevance Health worth $374K as of Q2 2026.
  • Aspire Private Capital sold 103 Elevance Health shares in Q2 2026, an estimated $38.2K.
  • Elevance Health made up 0.08% of Aspire Private Capital's portfolio in Q2 2026, its #134 holding.
  • Aspire Private Capital first reported a position in Elevance Health in Q4 2018 and has held it in 30 quarters since.
  • Aspire Private Capital's Elevance Health position peaked at $588K in Q3 2023.
  • 1,600 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Aspire Private Capital's 13F filing for Q2 2026, filed 15 Jul 2026.